In breast cancer, suppression of ELK3 in MDA-MB-231 cells resulted in the loss of metastatic characteristics, mainly by activating GATA binding protein 3 (GATA3) to regulate the expression of cell-cell adhesion factors and tight junctional proteins [12, 19]. This evidence concerns the gene GATA3 and breast cancer.